Skip to main content
logo
Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.5587
+0.0492 (9.66%)
Nov 9, 2026, 3:02 PM EST - Market open

Citius Oncology Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Income
-46.06-24.76-21.15-12.7-10.87
Stock-Based Compensation
13.348.327.51.97-
Other Operating Activities
0.191.060.580.581.15
Change in Inventory
-4.05-12.65-2.13--
Change in Accounts Payable
-1.359.522.421.20.18
Change in Other Net Operating Assets
15.0413.0212.918.969.53
Operating Cash Flow
-19.39-5.490.13--
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22
Sale (Purchase) of Intangibles
-12.75-5.75-5--
Investing Cash Flow
-12.75-5.75-5--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22
Long-Term Debt Issued
--3.8--
Net Debt Issued (Repaid)
9.64-3.8--
Issuance of Common Stock
39.9615.17---
Other Financing Activities
-0.89-1.07--
Financing Cash Flow
48.715.174.87--

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Cash Flow
16.563.920--

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22
Levered Free Cash Flow
-31.17-8.13-1.944.55-
Unlevered Free Cash Flow
-30.94-7.99-1.944.55-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash Interest Paid
0.40.19---
Change in Working Capital
8.959.8913.210.169.71
SEC Filings: 10-K · 10-Q